Neurosoft Bioelectronics – SOFT ECoG
Home > Success Stories >
EIC Accelerator / Direct funding by SERI
With more than 50 million cases worldwide, epilepsy is one of the most common brain disorders. Even though some treatments exist to alleviate this reality, anti-epileptic drugs fail in 30% of the patients, and cases sent to neurosurgeons often involve risks of complications and re-operation.
SOFT ECoG, developed by Neurosoft Bioelectronics, is a high-resolution and soft brain implant for monitoring and surgical treatment of epilepsy. This device will improve the rate of surgery, reducing associated problems and revolutionizing current treatments thanks to its soft materials, accurate recording of electric signals and more precise brain stimulation.
Neurosoft’s product has already been tested in various animal models, showing its efficacy and safety. Now, they are ready to move a step forward and develop the next-generation of neural implants.
